DSY DASSAULT SYSTEMES SA

Dassault Systèmes Signs the AI Pact to Drive Innovation and the Ethical Use of Artificial Intelligence in Europe

(Euronext Paris: FR0014003TT8, DSY.PA) today announced that it has signed the , a new initiative from the European Commission to establish best practices and minimize risks associated with the use of artificial intelligence in Europe, and help industry create value. By signing the pact, Dassault Systèmes demonstrates its commitment to playing a proactive role in encouraging innovation and the ethical use of AI in Europe following Europe’s AI Act.

The AI Pact was created by the European Commission to encourage and support organizations to plan ahead for the implementation of measures required by the AI Act, which went into effect on August 1, 2024. The AI Act aims to drive the transparent and regulated use of AI applications in Europe, in particular in high-risk use cases that could impact the safety and rights of citizens.

Companies that join the AI Pact commit to take concrete actions including adopting an AI governance strategy for the use of AI within their company, creating a map of trustworthy AI systems they deploy in high-risk sectors, and training their employees on using AI responsibly.

“For 40 years, we’ve worked with our customers to create a scientific representation of the world that combines AI, modeling and simulation in virtual twin experiences. This has driven major advancements in sustainable industrial innovation while protecting our customers’ most powerful competitive asset: their IP,” said Pascal Daloz, CEO, Dassault Systèmes. “By joining the AI Pact, we pledge to be a driving force in the responsible use of AI to open up innovative opportunities in the generative economy. As a trusted partner of equally committed companies, we will spearhead a collective effort to ensure that AI in Europe benefits citizens, patients and consumers.”

###

FOR MORE INFORMATION

Dassault Systèmes’ 3DEXPERIENCE platform, 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions:

SHARE THIS ON THE SOCIAL PLATFORM X

@Dassault Systèmes signs the AI Pact to drive innovation and the ethical use of artificial intelligence in Europe

Connect with Dassault Systèmes on

ABOUT DASSAULT SYSTÈMES

Dassault Systèmes is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers can redefine the creation, production and life-cycle-management processes of their offer and thus have a meaningful impact to make the world more sustainable. The beauty of the Experience Economy is that it is a human-centered economy for the benefit of all – consumers, patients and citizens. Dassault Systèmes brings value to more than 350,000 customers of all sizes, in all industries, in more than 150 countries. For more information, visit

© Dassault Systèmes. All rights reserved. 3DEXPERIENCE, the 3DS logo, the Compass icon, IFWE, 3DEXCITE, 3DVIA, BIOVIA, CATIA, CENTRIC PLM, DELMIA, ENOVIA, GEOVIA, MEDIDATA, NETVIBES, OUTSCALE, SIMULIA and SOLIDWORKS are commercial trademarks or registered trademarks of Dassault Systèmes, a European company (Societas Europaea) incorporated under French law, and registered with the Versailles trade and companies registry under number 322 306 440, or its subsidiaries in the United States and/or other countries. All other trademarks are owned by their respective owners. Use of any Dassault Systèmes or its subsidiaries trademarks is subject to their express written approval.

EN
25/09/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DASSAULT SYSTEMES SA

 PRESS RELEASE

Medidata renforce son engagement en faveur de l’expérience du patient ...

NEW YORK--(BUSINESS WIRE)-- , marque de Dassault Systèmes et principal fournisseur de solutions d’essais cliniques pour l’industrie des sciences de la vie, a annoncé aujourd’hui le lancement de Medidata , une nouvelle solution qui harmonise les allocations et les remboursements liés aux essais pour les patients participant à la recherche clinique. Cette offre automatise le cycle de vie des paiements et répond au défi de longue date de compenser les participants pour leur temps, leurs efforts et les dépenses liées à l’étude, tout en répondant aux préoccupations croissantes concernant la toxicit...

 PRESS RELEASE

Dassault Systèmes Signs the AI Pact to Drive Innovation and the Ethica...

VELIZY-VILLACOUBLAY, France--(BUSINESS WIRE)-- (Euronext Paris: FR0014003TT8, DSY.PA) today announced that it has signed the , a new initiative from the European Commission to establish best practices and minimize risks associated with the use of artificial intelligence in Europe, and help industry create value. By signing the pact, Dassault Systèmes demonstrates its commitment to playing a proactive role in encouraging innovation and the ethical use of AI in Europe following Europe’s AI Act. The AI Pact was created by the European Commission to encourage and support organizations to plan ah...

 PRESS RELEASE

Medidata Extends Its Commitment to the Patient Experience with the Lau...

NEW YORK--(BUSINESS WIRE)-- , a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced the launch of Medidata , a new solution that streamlines trial-related stipends and reimbursements for patients participating in clinical research. This offering automates the payment lifecycle and addresses the longstanding challenge of compensating participants for their time, effort, and study-related expenses, while solving for growing concerns around the financial toxicity of clinical trial encounters. Medidata Patient Payments delivers a...

 PRESS RELEASE

Medidata reconnu comme leader dans l'évaluation inaugurale PEAK Matrix...

NEW YORK--(BUSINESS WIRE)-- Medidata, une marque de Dassault Systèmes et principal fournisseur de solutions d'essais cliniques pour l'industrie des sciences du vivant, a été qualifié de leader dans la toute première évaluation PEAK Matrix® d'Everest Group pour la saisie électronique des données (EDC) en matière de sciences du vivant. Le rapport, qui a évalué 20 fournisseurs, a mis en exergue de Medidata en raison de son intégration sans heurt avec les wearables, les capteurs et les EHR, ainsi que de ses fonctionnalités avancées en matière de vérification des données sources, de sa gestion de...

 PRESS RELEASE

Medidata Recognized as a Leader in Everest Group’s Inaugural Electroni...

NEW YORK--(BUSINESS WIRE)-- Medidata, a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry, has been recognized as a Leader in Everest Group‘s first-ever PEAK Matrix® Assessment for Electronic Data Capture (EDC) in life sciences. The report, which evaluated 20 providers, highlighted Medidata for its seamless integration with wearables, sensors, and EHRs, along with its advanced capabilities in source data verification, AI-driven query management, and adverse event handling. Rave EDC earned recognition for its intuitive, low-code design,...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch